Keyword

fevipiprant

Description: Fevipiprant is an oral small-molecule antagonist of the prostaglandin D2 receptor CRTh2, studied as a treatment for allergic asthma and nasal polyposis.
Wikidata ID: wiki/Q27077292
OpenAlex ID: keywords/fevipiprant
2016 · Veit J. Erpenbeck, Todor A. Popov, et al. · Pulmonary Pharmacology & Therapeutics · 106
2017 · Eric D. Bateman, Alfredo G. Guerreros, et al. · European Respiratory Journal · 104
2019 · Ruth Saunders, Himanshu Kaul, et al. · Science Translational Medicine · 80
2016 · David A. Sykes, Michelle E. Bradley, et al. · Molecular Pharmacology · 73
2017 · David A. Sandham, Lucy Barker, et al. · ACS Medicinal Chemistry Letters · 36
2019 · Corrado Pelaia, Claudia Crimi, et al. · Pharmacological Research · 34
2017 · Stephen P. Peters, William W. Busse · The Journal of Allergy and Clinical Immunology In Practice · 29
2018 · Christobelle White, Adam Wright, et al. · Expert Opinion on Investigational Drugs · 28
2022 · Philippe Gevaert, Claus Bachert, et al. · Journal of Allergy and Clinical Immunology · 22
2019 · Clare Hardman, Wentao Chen, et al. · Journal of Allergy and Clinical Immunology · 17
2020 · Gaurav Agnihotri, Peter A. Lio · Clinical Drug Investigation · 16
2019 · Christina C. Kao, Amit D. Parulekar · Journal of Asthma and Allergy · 16
2023 · Alexandros Kourentas, Monika Gajewska, et al. · The AAPS Journal · 14
2021 · Chris Brightling, Swarupa Kulkarni, et al. · Pulmonary Pharmacology & Therapeutics · 13
2020 · Huib A M Kerstjens, Reinoud Gosens · The Lancet Respiratory Medicine · 13
Works count: 101
Citation count: 1,407
Year
Topic
Type